February 12, 2009 - CIRS annoucned today that the CIRS Model 045 Brachytherapy QA Phantom used in conjunction with the CIRS Model 053G Ultrasound Prostate Phantom offers a complete solution for implementing a QA program specific to transrectal ultrasound used for guidance of prostate brachytherapy as recommended by AAPM Task Group 1281.

The Model 045 is designed to enable users to check key imaging parameters such as: depth of penetration, axial and lateral resolution, distance measurements, area measurements, volume measurements and geometric consistency with the treatment planning computer.

The Model 053G is a disposable product ideal for practicing seed implantations and can be used to verify alignment of the physical needle template with the electronic grid.

For more information: www.cirsinc.com


Additional Content

News | Artificial Intelligence

June 27, 2024 — The American College of Radiology (ACR) launched the ACR Recognized Center for Healthcare-AI (ARCH-AI) ...

Time June 27, 2024
arrow
News | Quality Assurance (QA)

November 25, 2023 — Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry ...

Time November 25, 2023
arrow
News | Quality Assurance (QA)

March 16, 2023 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery ...

Time March 16, 2023
arrow
News | Quality Assurance (QA)

October 7, 2022 — Mirion Technologies, Inc., a global provider of radiation detection, measurement, analysis and ...

Time October 07, 2022
arrow
News | Radiation Therapy

September 1, 2022 — IBA S.A., a leader in particle accelerator technology and a leader in dosimetry quality assurance ...

Time September 01, 2022
arrow
Subscribe Now